FDA Approves Tecovirimat, First Drug for Smallpox Treatment FDA Approves Tecovirimat, First Drug for Smallpox Treatment

Tecovirimat (TPOXX) provides a treatment option should smallpox ever be used as a bioweapon and is the first product to be awarded a material threat medical countermeasure priority review voucher.FDA Approvals
Source: Medscape Internal Medicine Headlines - Category: Internal Medicine Tags: Infectious Diseases News Source Type: news